NCT00046930 Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia Status COMPLETED Phase PHASE3
NCT00046852 Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00043979 Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas Status COMPLETED Phase PHASE2
NCT00041470 Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial Status TERMINATED Phase PHASE1/PHASE2
NCT00041327 Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma Status COMPLETED Phase PHASE2
NCT00041132 S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00041067 S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00040937 S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00040872 Multiple Therapies in Treating Patients With Advanced Neuroblastoma Status COMPLETED Phase PHASE2
NCT00040690 Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia Status COMPLETED Phase PHASE2
NCT00039481 Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00039377 Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00039195 Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma Status COMPLETED Phase PHASE2
NCT00039130 Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia Status COMPLETED Phase PHASE2
NCT00036855 Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma Status TERMINATED Phase PHASE1
NCT00035620 Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy Status COMPLETED Phase PHASE2
NCT00033696 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00032149 Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00032019 Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00031629 Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus Status COMPLETED Phase PHASE2